Baseline characteristics for discrete variables
| Characteristics | Number | Percentage |
| Male | 132 040 | 48.2 |
| Baseline anemia | 39 799 | 14.5 |
| Antidiabetic agent | ||
| Biguanide | 185 881 | 67.9 |
| Sulphonylurea | 173 525 | 63.4 |
| Insulin | 29 697 | 10.8 |
| Meglitinide | 27 | 0.01 |
| Dipeptidyl peptidase-4 inhibitor | 325 | 0.12 |
| Thiazolidinedione | 3698 | 1.35 |
| Glucagon-like peptide-1 agonist | 17 | 0.006 |
| Acarbose | 3292 | 1.20 |
| Cardiovascular drugs | ||
| ACEI/ARB | 121 786 | 44.5 |
| Beta-adrenergic receptor blocker | 92 309 | 33.7 |
| Calcium channel blocker | 109 225 | 39.9 |
| Diuretic | 52 096 | 19.0 |
| Lipid-lowering agent | 61 401 | 22.4 |
| Comorbidities | ||
| Diabetic renal complication | 3381 | 1.23 |
| PVD | 346 | 0.13 |
| Diabetic ophthalmological complication | 3543 | 1.29 |
| Ischemic Stroke | 8986 | 3.28 |
| SCD | 6420 | 2.34 |
| AF | 7772 | 2.84 |
| HF | 11 189 | 4.09 |
| Intracranial hemorrhage | 3264 | 1.19 |
| IHD | 26 423 | 9.65 |
| Osteoporosis | 137 | 0.050 |
| Dementia | 2842 | 1.04 |
| Hypertension | 64 246 | 23.5 |
| Chronic obstructive pulmonary disease | 818 | 0.299 |
| Cancer | 12 190 | 4.45 |
ACEI, angiotensinogen converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin receptor blocker; HF, heart failure; IHD, ischemic heart disease; PVD, peripheral vascular disease; SCD, sudden cardiac death.